AILERON THERAPEUTICS INC's ticker is ALRN and the CUSIP is 00887A105. A total of 31 filers reported holding AILERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $254,000 | -15.1% | 1,226,792 | +6.8% | 0.00% | 0.0% |
| Q2 2022 | $299,000 | -42.1% | 1,148,581 | +14.1% | 0.00% | -50.0% |
| Q1 2022 | $516,000 | -14.1% | 1,006,668 | -5.7% | 0.00% | 0.0% |
| Q4 2021 | $601,000 | -26.6% | 1,067,489 | +32.9% | 0.00% | -33.3% |
| Q3 2021 | $819,000 | -4.8% | 803,160 | +16.7% | 0.00% | 0.0% |
| Q2 2021 | $860,000 | +74.1% | 688,044 | +99.1% | 0.00% | +50.0% |
| Q1 2021 | $494,000 | +77.1% | 345,594 | +29.0% | 0.00% | +100.0% |
| Q4 2020 | $279,000 | -10.6% | 267,994 | +10.8% | 0.00% | 0.0% |
| Q3 2020 | $312,000 | +11.0% | 241,844 | +1.4% | 0.00% | 0.0% |
| Q2 2020 | $281,000 | +178.2% | 238,544 | -21.5% | 0.00% | 0.0% |
| Q1 2020 | $101,000 | -49.2% | 303,944 | -12.7% | 0.00% | 0.0% |
| Q4 2019 | $199,000 | +521.9% | 348,044 | +632.7% | 0.00% | – |
| Q3 2019 | $32,000 | +3.2% | 47,500 | +9.7% | 0.00% | – |
| Q2 2019 | $31,000 | -27.9% | 43,300 | +98.1% | 0.00% | – |
| Q1 2019 | $43,000 | – | 21,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 16,609,449 | $4,318,000 | 8.01% |
| KCK LTD. | 646,817 | $168,000 | 0.24% |
| Ikarian Capital, LLC | 2,892,316 | $752,000 | 0.14% |
| BVF INC/IL | 5,265,555 | $1,369,000 | 0.07% |
| Urban Wealth Management, LLC | 37,314 | $10,000 | 0.03% |
| Game Plan Financial Advisors, LLC | 103,000 | $27,000 | 0.02% |
| RIDGECREST WEALTH PARTNERS, LLC | 10,000 | $3,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 278,743 | $72,000 | 0.00% |
| Taconic Capital Advisors LP | 135,000 | $35,000 | 0.00% |
| BLAIR WILLIAM & CO/IL | 1,148,581 | $299,000 | 0.00% |